Guidance for Ironwood Pharmaceuticals (IRWD)

Period Range Estimate Revenue Range Revenue Estimate Target Details
2026 N/A N/A $450.00M – 475.00M $410.50M = Maintained Details
2025 N/A N/A $290.00M – 310.00M $279.40M = Maintained Details
2025 N/A N/A $260.00M – 290.00M $286.80M = Maintained Details
2025 N/A N/A $260.00M – 290.00M $287.60M = Maintained Details
2024 N/A N/A $350.00M – 375.00M $357.10M = Maintained Details
2024 N/A N/A $350.00M – 375.00M $410.10M = Maintained Details
2024 N/A N/A $405.00M – 425.00M $447.80M = Maintained Details
Q1 2024 N/A N/A $435.00M – 455.00M $462.90M = Maintained Details
2023 N/A N/A $435.00M – 450.00M $427.90M = Maintained Details
2023 N/A N/A $420.00M – 435.00M $426.40M = Maintained Details
Q4 2023 N/A N/A $435.00M – 450.00M $438.60M = Maintained Details
2022 N/A N/A $420.00M – 430.00M $422.70M = Maintained Details
2022 N/A N/A $420.00M – 430.00M $428.80M = Maintained Details
2022 N/A N/A $420.00M – 430.00M $430.00M = Maintained Details
2021 N/A N/A $390.00M – 410.00M $408.00M = Maintained Details
2021 N/A N/A $390.00M – 410.00M $392.00M = Maintained Details
2021 N/A N/A $370.00M – 385.00M $315.23M = Maintained Details
2021 N/A N/A $370.00M – 385.00M $427.50M Lowered Details
2020 N/A N/A $360.00M – 380.00M $391.25M = Maintained Details
2019 N/A N/A $410.00M – 420.00M $377.39M = Maintained Details
2019 N/A N/A $370.00M – 390.00M $388.20M = Maintained Details
2019 N/A N/A $370.00M – 390.00M $377.33M = Maintained Details
Q3 2018 N/A N/A N/A N/A = Maintained Details
Q2 2018 N/A N/A N/A N/A = Maintained Details
Q1 2018 N/A N/A N/A N/A = Maintained Details
Q4 2017 N/A N/A N/A N/A = Maintained Details
Q3 2017 N/A N/A N/A N/A = Maintained Details
Q2 2017 N/A N/A N/A N/A = Maintained Details
Q1 2017 N/A N/A N/A N/A = Maintained Details